Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...

Indian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...

Nifty broke below its 23,800–24,500 consolidation range, signalling near-term weakness, with resistance now seen at 23,800–24,000 and key s...

Indian markets anticipate the US Fed's decision and election exit polls today. Key companies including HUL, Bajaj Finance, and Adani Power ...

Nifty ended flat but extended gains, with technical indicators signaling a bullish bias above key support. Analysts highlight Craftsman Aut...

Laurus Labs stock price increased following Andhra Pradesh government's land allotment. The company will establish Laurus Pharma Zone in An...

Technical analysis identifies select stocks that may gain momentum even in volatile markets. Picks by the technical charts today.

Market expert Aamar Singh analyzes the current market situation. Nifty's pullback is expected, but further selling pressure is possible. Si...

The Indian market is predicted to rise, fueled by positive domestic signals and increased optimism in the options market. Traders are showi...

Laurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity for short-term...

Laurus Labs Ltd stock dropped by over 10% from its peak in July 2024 but found support above the 200-day EMA. Experts predicted a potential...

“Since August, Laurus Labs stock price has been underperforming and it actually went from the levels of 400 odd to nearly 350. But 350 turn...

Stocks that were in focus included names like Kotak Mahindra Bank, which rose 1.85%, Laurus Labs, which gained 9.47%, and Vedanta, whose sh...

Stocks that were in focus included names like NMDC, which rose 5.42%, Britannia, which rose 0.1%, and Laurus Labs, whose shares jumped 0.14...

The Relative Strength Index (RSI) is a valuable technical indicator for assessing a stock's price momentum and can help investors make info...

Laurus Labs is set to increase its stake in Immunoadoptive Cell Therapy (lmmunoACT) by 7.24% for $10.6m, taking its total stake in the comp...

Here is a lowdown on what happened in Monday’s market.